Laprituximab
Modify Date: 2024-01-11 12:45:24
Laprituximab structure
|
Common Name | Laprituximab | ||
|---|---|---|---|---|
| CAS Number | 1622327-38-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LaprituximabLaprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289[1]. |
| Name | Laprituximab |
|---|
| Description | Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289[1]. |
|---|---|
| Related Catalog | |
| In Vivo | 在 H292 异种移植瘤模型中，Laprituximab (J2898A) 的最低有效剂量为 3 mg/kg[1]。 |
| References |
| No Any Chemical & Physical Properties |